Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Vibration for Pain During Botox for Spasmodic Dysphonia
NCT04648891Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in Spasmodic dysphonia (SD), sponsored by Mayo Clinic. Started Aug 2021; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Spasmodic dysphonia (SD)
Beyond the preview
Go deeper on NCT04648891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648891.